Λίστα αντικειμένων
A retrospective study, The combination of thiotepa, busulfan fludarabine (TBF) reduces the risk of relapse in patients with remission AML, as compared to myeloablative busulfan fludarabine (BUFLU)The effect is independt of donor type and GvHD prophylaxis.
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Vadratsikas
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Spyridis, Dr Fragopanagou, Dr Vadratsikas